W David Strain1, P M Paldánius2,3. 1. Diabetes and Vascular Research Centre, Institute of Biomedical and Clinical Science, University of Exeter Medical School, Royal Devon & Exeter NHS Foundation Trust, Barrack Road, Exeter, UK. d.strain@exeter.ac.uk. 2. Novartis Pharma AG, Basel, Switzerland. 3. Research Group for Clinical and Molecular Metabolism (CAMM), Children's Hospital, Helsinki University Hospital (HUS), Helsinki University, Helsinki, Finland.
Authors: Kyoung Min Kim; Kyong Yeun Jung; Han Mi Yun; Seo Young Lee; Tae Jung Oh; Hak Chul Jang; Soo Lim Journal: Cardiovasc Diabetol Date: 2017-11-09 Impact factor: 9.951